University of Dundee, MSc Human Clinical Embryology and Assisted Conception - Apply now for September 2018
Page URL: https://www.bionews.org.uk/page_92537

Will the public trust a single regulator for research?

30 August 2010
By Simon Denegri
CEO, Association of Medical Research Charities (AMRC)
Appeared in BioNews 573
In these uncertain times, a single regulator for research is one of the safer bets you might place.

The UK's Department of Health has signalled its own preference for such a body in its review of Arm's Length Bodies. The Academy of Medical Science is gathering opinions as part of its independent inquiry into medical research regulation. It is perhaps more a question of 'when' and 'how' rather than 'if' such a body will be created.

Many patients represented by the Association of Medical Research Charities (AMRC)'s member charities will welcome the advent of a single regulator if it means research involving them is safe but easier and quicker to accomplish. They will know already the regulatory difficulties that researchers and funders can face in getting work off the ground. They will have helped voice this frustration in parliament and the media.

As for the wider public, I suspect they will be largely ignorant of its work but trusting in its existence. As in other areas - such as animal research - they will view it as an important factor contributing to their view that things are being done in the right way, but not the only one.

My hope is that a single regulator would be adventurous in its outlook as it thinks about this relationship. As custodian of the public's trust it will be well-placed to play a significant if not pivotal role in strengthening the partnership between researchers, patients and the public. But it must set about this task from the very beginning. And it must be integral to the way it talks, breathes and behaves as a body.

Fortunately it has many precedents and models to learn from in the shape of the Human Tissue Authority (HTA), Human Fertilisation and Embryology Authority (HFEA), National Institute for Health and Clinical Excellence (NICE) and others. This week I was sent a workshop report from the UK Biobank Ethics and Governance Council on involving publics in biobank research and governance looking at a range of ideas from citizens' inquiries to citizens' panels. The ideas are out there. The real question is whether it will be brave enough to adopt, adapt and innovate.

As I talk to patients and charities, it is interesting to me that the vast majority are drawing a very strong distinction between the single regulator involving patients and the public in its work, and it having a role in public engagement.

On the former, there is an almost unanimous desire to see mechanisms put in place which involve patients and the public and that are aimed at ensuring good governance, accountability and transparency. Yet they are lukewarm, at best, on the idea that single regulator should venture into the realms of public engagement. Too often have they seen it used as a well-intentioned smokescreen for developing a more business-like relationship with patient groups, patients and the public.

The bottom line is medical research is increasingly a shared endeavour between researchers and patients. If a single regulator can reflect this in the way it works, then we will have reason to trust it.

SOURCES & REFERENCES
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
13 August 2012 - by Dr Vanita Rasiah 
Here's an idea - what if the key to improved treatment of some of the most problematic medical conditions lay buried in a vast mass of patient data siloed in archaic computer systems? What if researchers couldn't get to it thanks to an impenetrable cat's cradle of red tape?...
19 December 2011 - by Sharmila Nebhrajani 
Our medical records include some of the most personal and sensitive information about us. So it's understandable that two items in David Cameron's life sciences strategy caused considerable stir...
23 August 2010 - by Professor Eric Blyth, Dr Marilyn Crawshaw, Dr Lucy Frith, Dr Caroline Jones and Dr Jennifer Speirs 
The UK government's review of Arm's Length Bodies (ALB) in the National Health Service has indicated that the Human Fertilisation and Embryology Authority (HFEA) has had its day as a free-standing regulatory body...
16 August 2010 - by Naomi Moskovic 
This book is written by a lawyer who is both an expert in family law, and also, as she puts it herself 'a player in the fertility game'. Cahn is a research Professor of Law at Washington University Law School, and this book examines the position under US law.
16 August 2010 - by Professor Alison Murdoch 
The UK's new government plans to divide the responsibilities of the Human Fertilisation and Embryology Authority (HFEA) between different existing organisations to reduce the cost and burden of regulation. This would see the end of the HFEA as we know it...
9 August 2010 - by Baroness Ruth Deech 
Of course we are all against unnecessary regulation: and one of the areas of policy put forward by the new coalition government which has seemed to attract widespread support, even from those who hold no brief for them, is the abolition of superfluous quangos....
2 August 2010 - by Dr Evan Harris 
In its quick review of Arm's Length Bodies, published last week, the Government announced the HFEA would be disbanded. The news was welcomed by some, criticised by others and the HFEA put out a fairly terse statement...
26 July 2010 - by Dr Vivienne Raper 
The UK's fertility watchdog, the Human Fertilisation and Embryology Authority (HFEA), could be split up as the Government's 'bonfire of the quangos' continues....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.